Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)
China
· Delayed Price · Currency is CNY 35.34
+0.09 (0.26%)
Apr 30, 2026, 3:12 PM CST
SHE:300683 Revenue
Wuhan Hiteck Biological Pharma Co.,Ltd had revenue of 159.05M CNY in the quarter ending March 31, 2026, with 1.52% growth. This brings the company's revenue in the last twelve months to 543.82M, down -19.28% year-over-year. In the year 2025, Wuhan Hiteck Biological Pharma Co.,Ltd had annual revenue of 541.45M, down -16.57%.
Revenue (ttm)
543.82M
Revenue Growth
-19.28%
P/S Ratio
8.48
Revenue / Employee
415.45K
Employees
1,309
Market Cap
4.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 541.45M | -107.52M | -16.57% |
| Dec 31, 2024 | 648.97M | 46.69M | 7.75% |
| Dec 31, 2023 | 602.28M | -86.34M | -12.54% |
| Jan 1, 2023 | 688.63M | 73.94M | 12.03% |
| Jan 1, 2022 | 614.68M | 90.56M | 17.28% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Jan 1, 2020 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Tibet Weixinkang Medicine | 1.16B |
| Shandong Sinobioway Biomedicine | 274.81M |
| Jinling Pharmaceutical Company | 3.16B |
| Newland Pharmaceutical | 659.54M |
| Jinhe Biotechnology CO., LTD. | 2.88B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |
| Hunan Fangsheng Pharmaceutical | 1.79B |